NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 73 filers reported holding NEOS THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $191,000 | +57.9% | 73,255 | 0.0% | 0.00% | – |
| Q4 2018 | $121,000 | -41.3% | 73,255 | +72.9% | 0.00% | – |
| Q3 2018 | $206,000 | -22.3% | 42,374 | 0.0% | 0.00% | -100.0% |
| Q2 2018 | $265,000 | -16.4% | 42,374 | +10.8% | 0.00% | 0.0% |
| Q1 2018 | $317,000 | -20.4% | 38,250 | -1.9% | 0.00% | 0.0% |
| Q4 2017 | $398,000 | +11.8% | 39,010 | +0.2% | 0.00% | 0.0% |
| Q3 2017 | $356,000 | +43.0% | 38,915 | +14.1% | 0.00% | 0.0% |
| Q2 2017 | $249,000 | -5.7% | 34,115 | -6.8% | 0.00% | 0.0% |
| Q1 2017 | $264,000 | +59.0% | 36,615 | +29.3% | 0.00% | – |
| Q4 2016 | $166,000 | -13.5% | 28,315 | -2.7% | 0.00% | – |
| Q3 2016 | $192,000 | -28.1% | 29,115 | +1.0% | 0.00% | -100.0% |
| Q2 2016 | $267,000 | +107.0% | 28,815 | +140.1% | 0.00% | – |
| Q1 2016 | $129,000 | -11.6% | 12,000 | +17.6% | 0.00% | – |
| Q4 2015 | $146,000 | -31.1% | 10,200 | +1.0% | 0.00% | -100.0% |
| Q3 2015 | $212,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |